고관절 골절환자에서 한국인 FRAX^® 모델의 효용성 = Clinical Efficacy of Korean FRAX^Ⓡ Model in Patients with Hip Fracture

다국어 초록 (Multilingual Abstract)

Objectives: We aimed to examine clinical efficacy of Korean FRAX model with respect to prediction of osteoporotic fracture risk and eligibility of osteoporosis treatment in Korean patients with hip fractures.

Materials & Methods: In 41 elderly patients with a proximal femoral fracture (mean age=78.7 years, range: 63～99 years), fracture probabilities were calculated using FRAX models from Korea and Japan. We then performed comparative analyses between ten-year probabilities of major / hip osteoporotic fractures and the osteoporosis treatment eligibilities based on the FRAX model from Korea and Japan.

Results: The mean ten-year probabilities of major osteoporotic fractures and hip fractures using the Korean FRAX model (11.5% and 5.9%, respectively) were significantly lower than those using the Japanese FRAX model (21.5% and 9.2%, respectively, P<0.001). In addition, based on the National Osteoporosis Foundation guideline, pharmacological treatment of osteoporosis would be recommended in 38 patients (92.7%) by the Japanese FRAX model, while only in 30 patients (73.2%) by the Korean FRAX model (P= 0.037).

Conclusions: Our results suggest that the Korean FRAX model might underestimate osteoporotic fracture probabilities and eligibility of osteoporosis treatment in Korean patients with hip fracture.

참고문헌 (Reference)

1 Frassetto LA, "Worldwide incidence of hip fracture in elderly women: relation to consumption of animal and vegetable foods" 55 : 585-592, 2000

2 Riggs BL, "The worldwide problem of osteoporosis : Insights afforded by epidemiology" 17 (17): 505-511, 1995

3 Clark P, "The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)" 20 : 275-282, 2009

4 Kanis JA, "The effects of a FRAX revision for the USA" 21 : 35-40, 2010

5 Tuzun S, "Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study" 19 : 2011

6 Dubey A, "Hip Fracture epidemiology: a review" 28 : 497-506, 1999

7 Schuit SC, "Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study" 34 : 195-202, 2004

8 Kanis JA, "FRAX and the assessment of fracture probability in men and women from the UK" 19 : 385-397, 2008

9 Kanis JA, "FRAX and its applications to clinical practice" 44 : 734-743, 2009

10 Zebaze RMD, "Epidemiology of hip and wrist fractures in Cameroon, Africa" 14 : 301-305, 2003

11 Siu AL, "Early ambulation after hip fracture: effects on function and mortality" 166 : 766-771, 2006

12 Fink HA, "Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures" 11 : 250-259, 2008

13 Fujiwara S, "Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX)" 19 : 429-435, 2008

14 이동윤, "Determination of an Applicable FRAX Model in Korean Women" 대한의학회 25 (25): 1657-1660, 2010

15 Tosteson AN, "Cost-effective osteoporosis treatment thresholds: the United States perspective" 19 : 437-447, 2008

16 Magaziner J, "Changes in functional status attributable to hip fracture: a comparison of hip fracture patients to communitydwelling age" 157 : 1023-1031, 2003

17 Siris ES, "Bone mineral density thresholds for pharmacological intervention to prevent fractures" 164 : 1108-1112, 2004

18 van den Bergh JP, "Assessment of individual fracture risk: FRAX and beyond" 8 : 131-137, 2010

19 윤지열, "A Comparison of Three Different Guidelines for Osteoporosis Treatment in Patients with Rheumatoid Arthritis in Korea" 대한내과학회 25 (25): 436-446, 2010